Pediatric MRI sedation
Conditions
Interventions
Group S:single inhalation of 6% sevoflurane with a mask
Group K:intranasal ketamine 2 mg/kg
Sponsors
Children's Hospital of Chongqing Medical University
Eligibility
Sex/Gender
All
Age
1 Years to 6 Years
Inclusion criteria
Inclusion criteria: Patients corresponding to ASA physical status I or II, aged between 1 and 6 years, who failed intranasal dexmedetomidine sedation during routine clinical diagnostic 3.0 T MRI scanning, i.e., at 30 min postadministration, with no evidence of sedation, as assessed using the Modified Observer Assessment of Alertness and Sedation Scale were included in this trial
Exclusion criteria
Exclusion criteria: Exclusion criteria were allergy to any drug included in the protocol or the presence of contraindications to their use, a recent respiratory infection or episode of acute asthma in the preceding 2 weeks, difficult airway or risk of upper airway obstruction, behavioral problems, gastroesophageal reflux disease, intracranial hypertension or serious neurological impairment, cardiac arrhythmia and known congenital heart disease.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| sucess rate;induction time;scan time;recovery time;time to return to baseline functional status ;occurrence of adverse events;Satisfaction score; | — |
Countries
China
Contacts
Public ContactLiu Wei
Children's Hospital of Chongqing Medical University
Outcome results
None listed